WORCESTER, Mass., Sept. 8, 2011 (GLOBE NEWSWIRE) -- RXi Pharmaceuticals Corporation (Nasdaq:RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics, today announced that Mark J. Ahn, President and CEO, will present a corporate overview at the 13th Annual Rodman & Renshaw Healthcare conference. The presentation will take place on Monday, September 12, 2011 at 4:30 pm EDT at the Waldorf Astoria Hotel in New York, NY.
The presentation will be webcast and available on the Investors section of the Company's website at www.rxipharma.com.
About RXi Pharmaceuticals Corporation
RXi Pharmaceuticals Corporation (Nasdaq:RXII) is a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics. For more information, visit www.rxipharma.com.
The RXi Pharmaceuticals Corporation logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10128
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about the future expectations, plans and prospects of the development of RXi Pharmaceuticals Corporation's products. These forward-looking statements about future expectations, plans and prospects of the development of the Company's products are subject to a number of risks, uncertainties and assumptions, including those identified under "Risk Factors" in the Company's most recently filed Annual Report on Form 10-K, Quarterly Report on Form 10-Q and in other filings the Company periodically makes with the SEC. Actual results may differ materially from those contemplated by these forward-looking statements. The Company does not undertake to update any of these forward-looking statements to reflect a change in its views or events or circumstances that occur after the date of this presentation.